Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models-Reference-Cited by-同舟云学术

Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

Published:2022-04-01 Issue:11 Volume:71 Page:2691-2700
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Žilionytė Karolina^ORCID,Bagdzevičiūtė Ugnė,Mlynska Agata,Urbštaitė Elena,Paberalė Emilija,Dobrovolskienė Neringa,Krasko Jan Aleksander,Pašukonienė Vita

Funder

Lietuvos Mokslo Taryba

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03190-9.pdf

Reference31 articles.

1. Bai R, Chen N, Li L et al (2020) Mechanisms of cancer resistance to immunotherapy. Front Oncol 10:1–12. https://doi.org/10.3389/fonc.2020.01290

2. Darvin P, Toor SM, Sasidharan Nair V, Elkord E (2018) Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50:1–11. https://doi.org/10.1038/s12276-018-0191-1

3. Calmeiro J, Carrascal MA, Tavares AR et al (2020) Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells. Pharmaceutics 12:1–20. https://doi.org/10.3390/pharmaceutics12020158